HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomized comparison of midazolam and diazepam for sedation in upper gastrointestinal endoscopy.

Abstract
One hundred and eighty-five patients were allocated at random to receive pethidine with diazepam (in an emulsion), or pethidine with midazolam i.v. as sedation for upper gastrointestinal endoscopy. Sedation and conditions for examination were comparable and satisfactory in both groups. Midazolam produced more amnesia (P = less than 0.001), and scored higher in patients' opinion (P = less than 0.001); it was associated with a slightly greater frequency of venous sequelae, but the difference in thrombophlebitis was not statistically significant. Recovery of sensory--motor performance, as assessed by Trieger test, was still incomplete 2 h after endoscopy with both drug regimens.
AuthorsV C Magni, R A Frost, J W Leung, P B Cotton
JournalBritish journal of anaesthesia (Br J Anaesth) Vol. 55 Issue 11 Pg. 1095-101 (Nov 1983) ISSN: 0007-0912 [Print] England
PMID6139120 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Anxiety Agents
  • Hypnotics and Sedatives
  • Benzodiazepines
  • Diazepam
  • Midazolam
Topics
  • Adolescent
  • Adult
  • Aged
  • Amnesia
  • Anti-Anxiety Agents (adverse effects, pharmacology)
  • Benzodiazepines (adverse effects, pharmacology)
  • Cholangiopancreatography, Endoscopic Retrograde
  • Diazepam (adverse effects, pharmacology)
  • Digestive System
  • Endoscopy
  • Female
  • Humans
  • Hypnotics and Sedatives
  • Male
  • Midazolam
  • Middle Aged
  • Patient Acceptance of Health Care
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: